Dear Editor,

Glioma is known for its morphologic and molecular diversity. Clinically documented glioma with epithelial differentiation is rare and linked to poor prognosis with unknown mechanisms.[^1^](#ctm2165-bib-0001){ref-type="ref"}, [^2^](#ctm2165-bib-0002){ref-type="ref"} We identified an epigenetically modulated and stress‐related glioma epithelial transcriptional program showing correlation with aggressiveness, recurrence and prognosis in glioma patients, and highlighted ΔNp63 as a likely driver of this cellular plasticity. The study flow diagram is shown in Figure S1.

We applied the GENIE3 algorithm[^3^](#ctm2165-bib-0003){ref-type="ref"} to transcriptomes of 212 heterogeneous Gene Expression Omnibus brain samples with genes prefiltered by correlation (Pearson\'s *R* \> 0.8) for regulatory network reconstruction. Regulons, namely regulatory relationships, were established concerning 37 core transcription factors (TFs) (top 1% most confident regulations and ≥10 targets). Based on connections among TFs (Table S1), we aggregated the regulons to eight clusters denoted C1 to C8. Nearly all these regulon clusters were univariately associated with prognosis in TCGA glioma patients (Figure S2A). However, only one regulon cluster, the C6 containing 8 TFs and 76 targets, showed independent prognostic significance after adjustment for established glioma prognosticators (Figure S2B). Markers as well as regulators for epithelial differentiation were enriched in C6 genes. We further deconvoluted C6 into two major subsets of genes (Figure S3), with the larger (n = 37) as C6a, which mainly consisted of end targets including epithelial/keratinocyte markers (e.g., cytokeratins), and the smaller (n = 18) as C6b, which mainly consisted of upstream regulators including *TP63* (key regulator of basal/squamous subtype carcinoma) and *MACC1* (coactivator of the receptor tyrosine kinase gene *MET* also involved in basal/squamous subtype carcinoma)[^4^](#ctm2165-bib-0004){ref-type="ref"} (Table S2). Higher C6b expression was found in glioblastoma (GBM) versus low grade glioma and in recurrent versus primary tumors (Figure S2C). High C6b was an independent predictor for unfavorable prognosis in glioma (Figure S2D).

We developed a network‐based approach to prioritize key C6 regulators using scRNA‐seq data (n = 658). *MET* and its canonical ligand *HGF*, as well as a classical regulator for glioma stemness and metastasis, *CD44*, were considered in addition to C6b genes.[^5^](#ctm2165-bib-0005){ref-type="ref"} Single cells were clustered to three subpopulations (Figure [1A](#ctm2165-fig-0001){ref-type="fig"}, left). The highest C6b expression and rate of cells expressing *CD44*, *TP63*, *MET*, and *MACC1* were found in one single‐cell cluster (Figure [1A](#ctm2165-fig-0001){ref-type="fig"}, middle and right; Table S3). Coexpression dependency network analysis demonstrated *TP63*, *MET*, and *MACC1* as the top three regulators (Figure [1B](#ctm2165-fig-0001){ref-type="fig"}, left; Table S4). Correlation dynamics analysis revealed higher connectivity among these three genes in samples presenting higher expression, suggesting positive regulatory circuit (Figure [1B](#ctm2165-fig-0001){ref-type="fig"}, right).

![Identification and validation of crucial regulators in C6b. **A,** The single cells could be classified to three clusters. The highest C6b expression level, as well as the highest rate of cells expressing *CD44*, *TP63*, *MET*, and *MACC1*, was found in one single cell cluster. **B,** The regulation dependency network of C6b (Supporting Information Methods), the red cycles represented the top three regulators in the overall regulatory program, and all other genes in gray cycles (**left**). The connectivity dynamics among these three genes in a series of subset of 98 sample of GSC, GBM, and NSC by each time removing the bottom 10% samples in terms of *TP63* expression (**right**). **C,** DNA CpG methylation status of *TP63*, *MET*, and *MACC1* in TCGA glioma samples within the top and bottom 25% in terms of C6b overall expression (GSVA score) (**left**). The expression and DNA CpG methylation status in samples (GSC17, GSC18, and GSC20) with highest global expression of *TP63*, *MET*, and *MACC1*, and a sample (GSC36) expressing none of these genes (**right**). **D,** The CHIP‐seq‐derived H3K27ac histone modification peaks in the above‐mentioned samples](CTM2-10-e165-g001){#ctm2165-fig-0001}

Genetic alterations of *TP63*, *MET*, and *MACC1* were rare in glioma (Figure S4). Thus, an epigenetically mediated activation was suspected. We examined the CpG methylation of *TP63*, *MET*, and *MACC1* in TCGA samples from top and bottom quarter regarding C6b expression. We found for all these genes a significantly lower CpG methylation level in the top quarter (Figure [1C](#ctm2165-fig-0001){ref-type="fig"}, left). However, in GSC models, there was no difference in CpG methylation between the three models showing highest overall expression (GSC17, GSC18, and GSC20) and the one expressing none of the three genes (GSC36), suggesting a role of other epigenetic mechanisms (Figure [1C](#ctm2165-fig-0001){ref-type="fig"}, right). We found multiple H3K27ac modification peaks detected around the *TP63*, *MET*, and *MACC1* genomic regions in GSC17, GSC18, and GSC20, but not in GSC36 (Figure [1D](#ctm2165-fig-0001){ref-type="fig"}). These observations suggest coordinated epigenetics for switching on the expression of the key regulators.

Differential expression and functional impact of p63 isoforms have been reported.[^6^](#ctm2165-bib-0006){ref-type="ref"} We found the ΔNp63 was the primary isoform expressed in glioma bulk tumors (ΔNp63, n = 589; TAp63, n = 46; Figure S5). Significant positive correlation was found between expression of epithelial markers and ΔNp63 but not TAp63 (Figure [2A](#ctm2165-fig-0002){ref-type="fig"}), and higher expression of these markers were presented in tumors expressing ΔNp63 compared to those expressing TAp63 at matched level (Figure [2B](#ctm2165-fig-0002){ref-type="fig"}). No co‐occurrence of these two isoform types was revealed at single cell level, and cells expressing ΔNp63 showed significantly decreased expression and altered exon usage of genes involved in cell cycle and RNA splicing compared to cells expressing TAp63, indicating a stressed phenotype as according to a previous report that stress responses induced by ɣ‐irradiation, hypoxia, and chemotherapy are all associated with downregulation and splicing alteration of genes involved in cell cycling as well as pre‐mRNA splicing machinery in cancer cells (Figure [2C‐E](#ctm2165-fig-0002){ref-type="fig"}).[^7^](#ctm2165-bib-0007){ref-type="ref"} We also found in bulk tumors a significant positive correlation between expression of C6 genes involved in response to stress and ΔNp63 but not TAp63 (Figure S6). Thus, selection pressure by hypoxia and chemoradiation may via stress response cascade lead to resistance linked with lineage plasticity such as epithelial differentiation. In glioma cell lines with adequate *TP63* expression (n = 10), we observed a positive correlation between expression of epithelial markers and ΔNp63 but not TAp63 transcripts, coherent with findings in bulk tumors (Figure S7). CRISPR/Cas9‐mediated functional screening revealed that only the two cell lines presenting high *TP63* expression with ΔNp63 as dominant showed significant decrease in cell viability following *TP63* knockout, while almost no effect in others (Figure [2F](#ctm2165-fig-0002){ref-type="fig"}; Table S5). These data altogether demonstrated stress‐related ΔNp63\'s isoform‐specific role as a master regulator driving epithelial differentiation in glioma.

![Determination of p63 isoforms and functional implications. **A,** Isoform‐specific correlation between expression of epithelial differentiation markers and ΔNp63/TAp63. Significance: \*\*\**P* \< .001; \*\**P* \< .01; \**P* \< .05; n.s., nonsignificant. **B,** Differential expression of epithelial markers in tumors expressing ΔNp63 and TAp63. **C,** Representative illustration of p63 isoforms in single GBM cells and glioma cell lines. **D,** Heatmap showing the first seven exons involved in alternative promoter usage in 37 single GBM cells by which the TAp63/ΔNp63 constitution could be determined. **E,** Comparison of the overall expression level (GSVA scores) of genes involved in cell cycle (Gene ontology, GO:0007049) and RNA splicing (GO:0006397, GO:0000377, GO:008380, GO:0000398, and GO:0000375) between the cells presenting TAp63 and ΔNp63 isoforms (**top**). Functional enrichment analysis for Gene Ontology Biological Process (GOBP) concerning genes with significantly different exon usage between the two groups of GBM cells (**bottom**). **F,** Association between *TP63* genetic dependency (CRISPR/CAS9‐mediated knockout effect on cell viability), *TP63* expression, and *TP63* isoform constitution in glioma cell lines with adequate *TP63* expression (log2(TPM+1) \> 1.5; n = 10). The two cell lines presenting high *TP63* expression with ΔNp63 as dominant showed significant decrease in cell viability following *TP63* knockout, while almost no effect in others](CTM2-10-e165-g002){#ctm2165-fig-0002}

Tumor heterogeneity and phenotypic plasticity are important aspects of cancer hall marks.[^8^](#ctm2165-bib-0008){ref-type="ref"} Glioma is well known for its morphologic and molecular diversity.[^9^](#ctm2165-bib-0009){ref-type="ref"} Our findings suggest an epithelial transcriptional program that exists in glioma and show correlation with disease progression, recurrence, and patients' survival. Our data highlighted the ΔN isoforms of *TP63* as a likely master regulator driving this cellular plasticity. Potential roles of epigenetic remodeling and cell stress response was also suggested, consistent with similar findings in previous studies.[^10^](#ctm2165-bib-0010){ref-type="ref"} Glioma cells with epithelial trans‐differentiation potential may contribute to the repertoire of tumor progression, treatment resistance, and metastasis, under natural or therapeutic selection pressure. The novel insights brought by this study form a new perspective and basis for further mechanistic and translational studies aiming to improve the understanding and management of glioma.

One limitation of this work is the retrospective nature of data used. Our multilevel multi‐omics strategy and rigorous statistical design could mitigate its potential effects. Besides, mechanistic exploration is limited at current stage. Nevertheless, the preliminary functional observations reported open a new path to fundamental glioma research.

In summary, we for the first time reported an epigenetically modulated and stress‐related glioma epithelial transcriptional program showing clinical significance, with ΔNp63 as a likely driving master regulator that interacts with *MET* signaling. Our findings deepen the understanding of glioma plasticity and provide novel insights for its management and research.
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